SLS Stock In The Spotlight As CEO Pushes Back On Regal Trial Criticism – ‘Let’s Separate The Noise From The Data’

Stergiou rejected claims that the trial delay means patients in the control group are living longer because of newer ...

Sellas Life Sciences: REGAL Trial's Delayed Events Signal Selection Bias

Sellas Life Sciences stock faces downside risk ahead of REGAL Phase 3 data, and the valuation looks stretched. Click here to ...
Asianet Newsable on MSN

SLS stock snaps 2-day slide: Sellas’ SLS009 AML trial spotlights big pharma drug combo from ABBV, RHHBY and BMY

SLS009 traces back to Sellas’ 2022 GenFleet licensing deal, when the company obtained rights outside Greater China to GFH009, ...

SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL As Most Bullish Pick

Traders are watching for the 80th event, data lock and topline results, while some are also speculating about potential M&A.

SELLAS Life Sciences Group, Inc.

View SELLAS Life Sciences Group, Inc. SLS stock quote prices, financial information, real-time forecasts, and company news from CNN.